Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Incyte (INCY) has drawn fresh attention after recent ...

Good morning, everyone. I'm Andy Berens, senior biotech analyst at Leerink Partners on day 2 of our Global Healthcare Conference in Miami. We're very happy to have with us Incyte. We have Pablo and ...

The U.S. Food and Drug Administration has declined to approve an additional indication for Zynyz, a cancer therapy developed by Incyte (INCY) and MacroGenics (MGNX), due to issues found at a ...

Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz (retifanlimab) for a second indication. The drug is now approved in the EU in ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Spider-Man: Across the Spider-Verse is merely the first half of a two-part story which means, unfortunately, we have a long wait ahead until Spider-Man: Beyond the Spider-Verse continues that ...

Spider-Man is one of the most iconic superheroes of all time, but he didn’t swing onto the big screen until director Sam Raimi helped bring 2002’s Spider-Man to life. Since then, Spider-Man has become ...

Spider-Man: Brand New Day is swinging into cinemas this July, and we now have finally seen the first trailer for the eagerly-awaited return of Tom Holland's Peter Parker following the dramatic events ...

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and ...